Infection, vaccines and other environmental triggers of autoimmunity

Autoimmunity

Volumn 38, Issue 3, 2005, Pages 235-245

  Molina, Vered ^a,b   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoimmune diseases; Autoimmunity; Infection; Molecular mimicry; Vaccine

Indexed keywords

AUTOANTIBODY; DIPHTHERIA VACCINE; HEPATITIS B VACCINE; HLA B27 ANTIGEN; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; POLIOMYELITIS VACCINE; TETANUS TOXOID;

ANKYLOSING SPONDYLITIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL INFECTION; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; GRAVES DISEASE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNE SYSTEM; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; NONHUMAN; OCCUPATIONAL EXPOSURE; PARASITOSIS; RHEUMATOID ARTHRITIS; RISK FACTOR; SEX DIFFERENCE; SILICONE PROSTHESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VACCINATION; VIRUS INFECTION; VIRUS MYOCARDITIS;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BACTERIAL INFECTIONS; BREAST IMPLANTS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INFECTION; INFLAMMATION; MALE; MOLECULAR MIMICRY; OCCUPATIONAL EXPOSURE; PARASITIC DISEASES; SEX FACTORS; SILICONE GELS; VACCINES; VIRUS DISEASES;

EID: 21844432906     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/08916930500050277     Document Type: Article

References (89)

1. Tishler M, Shoenfeld Y. Vaccination may be associated with autoimmune diseases. Isr Med Assoc J 2004;6:430-432.
2. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-920.
3. Yoon JW. The role of viruses and enviromnental factors in the induction of diabetes. Curr Top Microbiol Immunol 1990; 164:95-123.
4. Amital H, Shoenfeld Y. Autoimmunity and autoimmune diseases such as systemic lupus erythematosus. In: Lahita RG, editor. Systemic LUTUS erythematosus., 4th Ed., Amsterdam, The Netherlands: Elsevier Publication; 2004. p 3-27.
5. Shoenfeld Y, Isenberg DA. The mosaic of autoimmunity. Immunol Today 1989;10:123-126.
6. Shoenfeld Y, Isenberg DA. The mosaic of autoimmunity. (English). Holland: Elsevier; 1989. p 1-523.
7. Shoenfeld Y. Anti-DNA antibodies: Is DNA the self antigen or a shelf antigen, or are all autoimmune diseases immunogen driven? In: Lukic ML, Colic M, Stoikovic MM, Cuperlovic K, editors. Immunoregulation in health and disease. New York: Academic Press; 1997. p 139-148.
8. Shoenfeld Y, Lorber M, Yucel T, Yazici H. Primary antiphospholipid syndrome emerging following thymectomy for myasthenia gravis: Additional evidence for the kaleidoscope of autoimmunity. Lupus 1997;6:474-476.
9. Shoenfeld Y. The kaleidoscope of autoimmunity. Autoimmunity 1993;15:245-251.
10. Weiss P, Shoenfeld Y. Shifts in autoimmune diseases: The kaleidoscope of autoimmunity. Isr J Med Sci 1991;27: 216-217.
11. Shoenfeld Y, Rose N. Infection and autoimmunity. Amsterdam, The Netherlands: Elsevier Publication; 2004. p 1-630.
12. Abu-Shakra M, Shoenfeld Y. Chronic infections and autoimmunity: Molecular immunobiology of self reactivity. Immunol Ser 1991;55:285-313.
13. James JA, Neas BR, Moser KL, Hall T, Bruner GR, Sestak AL, Harley JB. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 2001;44:1122-1126.
14. Knox K, Brewer J, Henry J, et al. Human herpesvirus 6 and multiple sclerosis: Systemic active infections in patients with early disease. Clin Infect Dis 2000;31:894-903.
15. Moore F, Wolfson C. Human herpes virus 6 and multiple sclerosis. Acta Neurol Scand 2002;106:63-83.
16. Martyn C, Cruddas M, Compston D. Symptomatic Epstein-Barr virus infection and multiple sclerosis. J Neurol Neurosurg Psychiatry 1993;56:167-168.
17. Haahr S, Koch-Henriksen N, Moeller-Larsen A, Eriksen L, Andersen H. Increased risk of multiple sclerosis after late Epstein-Barr virus infection. Acta Neurol Scand 1997;169: 70-75.
18. Levin L, Munger K, Rubertone M, Peck C, Lennette E, Spiegelman D, Ascherio A. Multiple sclerosis and Epstein-Barr virus. J Am Med Assoc 2003;289:1533-1536.
19. Achiron A. Viruses and multiple sclerosis. In: Shoenfeld Y, Rose N, editors. Infection and autoimmunity. Amsterdam, The Netherlands: Elsevier Publication; 2004.
20. Hernan M, Zhang S, Lipworth L, Olek M, Ascherio A. Multiple sclerosis and age at infection with common viruses. Epidemiology 2001;12:301-306.
21. Guiducci S, Giacomelli R, Tyndall A, Matucci Cerinic M. Infection and systemic sclerosis. In: Shoenfeld Y, Rose N, editors. Infection and autoimmunity. Amsterdam, The Netherlands: Elsevier Publication; 2004.
22. Vaughan JH, Shaw PX, Nguyen MD, Medsger TA, Jr., Wright TM, Metcalf JS, LeRoy EC. Evidence of activation of 2 herpesvirus, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins. J Rheumatol 2000;27: 821-823.
23. Afanasyeva M, Rose NR. Viral infection and heart disease: Autoimmune mechanisms. In: Shoenfeld Y, Rose N, editors. Infection and autoimmunity. Amsterdam, The Netherlands: Elsevier Publication; 2004.
24. Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR. From infection to autoimmunity. J Autoimmun 2001;16: 175-186.
25. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987;139:3630-3636.
26. Molina V, Ehrenfeld M. Environmental factors in autoimmune diseases. Autoimmun Rev 2003;2:284-289, February 4-5, 2003, Durham, NC, USA.
27. Wucherpfennig KW. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Investig 2001;108: 1097-1104.
28. Mayes MD. Epidemiologic studies of environmental agents and systemic autoimmune diseases. Environ Health Perspect 1999;107(Suppl. 5):743-748.
29. Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity. Endocr Rev 1993;14:107-120.
30. Snider LA, Swedo SE. PANDAS: Current status and directions for research. Mol Psychiatry 2004; Jul 6 [Epub ahead of print].
31. Swedo SE, Snider LA, Garvey MA. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). In: Shoenfeld Y, Rose N, editors. Infection and autoimmunity. Amsterdam, The Netherlands: Elsevier Publication; 2004.
32. Blank K, Mai T, Gilbert I, Schiffmann S, Ranld J, Zivin R, Tackney C, Nicolaus T, Spinnler K, Oesterhelt F, Benoit M, Clausen-Schaumann H, Gaub HE. A force-based protein biochip. Proc Natl Acad Sci USA 2003; 30;100:11356-11360.
33. Blank M, Eisentin M, Asherson RA, Cervera R, Shoenfeld Y. The infectious origin of the antiphospholipid syndrome. In: Shoenfeld Y, Rose N, editors. Infection and autoimmunity. Amsterdam, The Netherlands: Elsevier Publication; 2004.
34. Blank M, Asherson RA, Cervera R, Shoenfeld Y. Antiphospholipid syndrome infectious origin. J Clin Immunol 2004; 24:12-23.
35. Blank M, Krause I, Fridkin M, Keller N, Kopolovic J, Goldberg I, Tobar A, Shoenfeld Y. Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Investig 2002;109:797-804.
36. Blank M, Shoenfeld Y. Beta-2-gllycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. Clin Immunol 2004;112:190-199.
37. Del Prete G, et al. Helicobacter pylori infection and gastric autoimmunity: Coincidence or cause-effect relationship? In: Shoenfeld Y, Rose N, editors. Infection and autoimmunity. Amsterdam, The Netherlands: Elsevier Publication; 2004.
38. Mattapallil JJ, Dandekar S, Canfield DR, Solnick JV. A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques. Gastroenterology 2000;118:307-315.
39. Sommer F, Faller G, Konturek P, Kirchner T, Hahn EG, Zeus J, Röllinghoff M, Lohoff M. Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun 1998; 66:5543-5546.
40. +-ATPase in human gastric autoimmunity. J Exp Med 2003;20(198): 1147-1156.
41. Showji Y, Nozawa R, Sato K, Suzuki H. Seroprevalence of Helicobacter pylori infection in patients with connective tissue diseases. Microbiol Immunol 1996;40:499-503.
42. Yazawa N, Fujimoto M, Kikuchi K, Kubo M, Ihn H, Sato S, Tamaki T, Tamaki K. High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: Association with oesophageal involvement. J Rheumatol 1998;4:650-653.
43. Alcocer-Varela J, Crispin Acuña JC. Infection and spondyloarthropathies. In: Shoenfeld Y, Rose N, editors. Infection and autoimmunity. Amsterdam, The Netherlands: Elsevier Publication; 2004.
44. Thurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez-Sueiro JL, Balish E, Hammer RE. The germ free state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994;180:2359-2364.
45. Abu-Shakra M, Shoenfeld Y. Parasitic infection and autoimmunity. In: Shoenfeld Y, Rose N, editors. Infection and autoimmunity. Amsterdam, The Netherlands: Elsevier Publication; 2004.
46. Abu-Shakra M, Buskila D, Shoenfeld Y. Molecular mimicry between host and pathogens: Examples from parasited implication. Immunol Lett 1999;67:147-152.
47. Abu-Shakra M, Shoenfeld Y. Parasitic infections and autoimmunity. Autoimmunity 1991;9:337-344.
48. Pollack S, Nagler A, Liberman D, Oren I, Alroy G, Katz R, Schechter Y. Immunological studies of pancytopenia in visceral leishmaniasis. Isr J Med Sci 1988;24:70-74.
49. Thomas MA, Frampton G, Isenberg DA, Shoenfeld Y, Akinsola A, Ramsay M. A common anti-DNA antibody idiotype and anti-phospholipid antibodies in sera from patients with schistosomiasis and filariasis with and without nephritis. J Autoimmun 1990;2:803-812.
50. Ravel G, Christ M, Horand F, Descotes J. Autoimmunity, environmental exposure and vaccination: Is there a link? Toxicology 2004;196:211-216.
51. Rubinstein E. Vaccination and autoimmune diseases: The argument against. Isr Med Assoc J 2004;6:433-435.
52. Aron-Maor A, Y. Vaccination and systemic lupus erythematosus: The bidirectional dilemmas. Lupus 2001;10(3): 237-240.
53. Aron-Maor A, Shoenfeld Y. Vaccination and autoimmunity. In: Shoenfeld Y, Rose N, editors. Infection and autoimmunity. Amsterdam, The Netherlands: Elsevier Publication; 2004.
54. Chen RT, Pless R, DeStefano FJ. Epidemiology of autoimmune reactions induced by vaccination. Autoimmunity 2001;16:309-318.
55. Borchers AT, Keen CL, Shoenfeld Y, Silva J, Jr, Gershwin ME. Vaccines, viruses, and voodoo. J Investig Allergol Clin Immunol 2002;12:155-168.
56. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity-'vaccinosis': A dangerous liaison? J Autoimmun 2000;14: 1-10.
57. Herroelen L, de Keyser J, Ebinger G. Central nervous system demyelination after immunization with recombinant Hepatitis B vaccine. Lancet 1991;338:1174-1175.
58. Nadler JP. Multiple sclerosis and Hepatitis B vaccination. Clin Infect Dis 1993;17:928-929.
59. Singh VK, Warren RP, Odell JD, Warren WL, Cole P. Antibodies to myelin basic protein in children with autistic behaviour. Brain Behav Immun 1993;7:97-103.
60. Shoenfeld Y, Aron-Maor A, Tanal A, Ehrenfeld M. BCG and autoimmunity: Another two-edged sword. JAI 2001; 16:235-240.
61. Aron-Maor A, Shoenfeld Y. BCG immunization and the 'Trojan Horse' phenomenon. Clin Rheum 2003;22:6-7.
62. Cohen AD, Shoenfeld Y. Vaccine-induced autoimmunity. J Autoimmun 1996;9:699-703.
63. Aharon-Maor A, Shoenfeld Y. The good, the bad and the ugly of vaccination. Isr Med Assoc J 2000;2:225-227.
64. Shoenfeld Y, Aharon-Maor A, Sherer Y. Vaccination as an additional player in the mosaic of autoimmunity. Clin Exp Rheumatol 2000;18:181-184.
65. Bar-Meir E, Eherenfeld M, Shoenfeld Y. Silicone gel breast implants and connective tissue disease - a comprehensive review. Autoimmunity 2003;36:193-197.
66. Bar-Meir E, Teuber SS, Lin HC, Alosacie I, Goddard G, Terybery J, Barka N, Shen B, Peter JB, Blank M, et al. Multiple autoantibodies in patients with silicone breast implants. J Autoimmun 1995;8:267-277.
67. Zandman-Goddard G, Blank M, Ehrenfeld M, Gilburd B, Peter J, Shoenfeld Y. A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants. J Rheumatol 1999;26:73-77.
68. Vermeulen RC, Scholte HR. Rupture of silicone gel breast implants and symptoms of pain and fatigue. J Rheumatol 2003;30:2263-2267.
69. Asherson RA, Shoenfeld Y, Jacobs P, Bosman C. An unusually complicated case of primary Sjogren's syndrome: Development of transient "Lupus-type" autoantibodies following silicone implant rejection. J Rheumatol 2004; 31:196-197.
70. Vasey FB, Zarabadi SA, Seleznick M, Ricca L. Where there's smoke there's fire: The silicone breast implant controversy continues to flicker: A new disease that needs to be defined. J Rheumatol 2003;30:2092-2094.
71. Janowsky EC, Kupper LL, Hulka BS. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 2000;342: 781-790.
72. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 1998;41:1714-1724.
73. D'Cruz D. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett 2000;112-113:421-432.
74. Lim SY, Ghosh SK. Autoreactive responses to an environmental factor: 1. Phthalate induces antibodies exhibiting anti-DNA specificity. Immunology 2003;110:482-492.
75. Lim SY, Ghosh SK. Autoreactive responses to an environmental factor: 2. Phthalate-induced anti-DNA specificity is downregulated by autoreactive cytotoxic T cells. Immunology 2004;112:94-104.
76. Whitacre CC, Reingold SC, O'Looney PA. Task force on gender, multiple sclerosis and autoimmunity. A gender gap in autoimmunity. Science 1999;283:1277-1278.
77. Cooper GS, Dooley MA, Treadwell EL, et al. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: Results of a population-based, case-control study. Arthritis Rheum 2002;46:1830-1839.
78. McMurray RW. Estrogen, prolactin, and autoimmunity: Actions and interactions. Int Immunopharmacol 2001;1:995-1008.
79. Heimer H. Outer causes inner conflicts: Environment and autoimmunity. Environ Health Perspect 1999;107:504-509.
80. D'Elios MM, Appelmelk BJ, Amedei A, Bergman MP, Prete GD. Gastric autoimmunity: The role of Helicobacter pylori and molecular mimicry. Trends Mol Med 2004; 10:316-323.
81. Pleister A, Eckels DD. Cryptic infection and autoimmunity. Autoimmun Rev 2003;2:126-132.
82. Raschi E, Testoni C, Bosisio D, Borghi MO, Koike T, Mantovani A, Meroni PL. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 2003;101:3495-3500.
83. Schwimmbeck PL, Yu DTY, Oldstone MB. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome: Molecular mimicry with Klebsiella pneumonia as potential mechanism of autoimmune disease. J Exp Med 1987;166:173-181.
84. Ringrose JH. HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27? Ann Rheum Dis 1999;58:598-610.
85. Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990;11:137-142.
86. Parham P. Presentation of HLA class I-derived peptides: Potential involvement in allorecognition and HLA-B27-associated arthritis. Immunol Rev 1997;154:137-154.
87. Powis SJ, Deverson EV, Coadwell WJ, et al. Effect of polymorphism of a MHC-linked transporter on the peptides assembled in a class I molecule. Nature 1992;357: 211-215.
88. Pearce RB, Trigler L, Svaasand EK, Peterson CM. Polymorphism in the mouse Tap-1 gene. Association with abnormal CD8 + T cell development in the non obese diabetic mouse. J Immunol 1993;151:5338-5347.
89. Maksymowych WP, Wessler A, Schmitt-Egenolf M, et al. Polymorphism in an HLA linked proteasome gene influences phenotypic expression of disease in HLA-B27 positive individuals. J Rheumatol 1994;21:665-669.